Rainbow Children's Medicare Ltd

CFO Resignation

• Vikas Maheshwari resigns as CFO and KMP, effective Aug 31, 2026, for personal reasons.
• Board has identified a prospective CFO candidate; appointment subject to formalities and regulatory disclosure.

Acquisition update

• Rainbow completes acquisition of 64% partnership interest and corresponding capital contribution in Super Prime Medical Care LLP.
• Acquisition followed PICTA dated July 29, 2026; completed August 14, 2026.
• Sellers are the existing partners of the LLP.

ESG rating update

• CRISIL ESG rated Rainbow at ESG 61 and Core ESG 73 for FY2025-26.
• Rating upgrade from Adequate to Strong for FY2023-24 and FY2024-25.
• Company did not engage CRISIL ESG; rating prepared independently from public-domain data.

Dematerialisation/rematerialisation filing

• RTA certified that details of dematerialized/rematerialized securities for the quarter were furnished to all stock exchanges.
• NSDL/CDSL certificates confirm that such details were furnished to stock exchanges.

Annual Report access notice

• Integrated Annual Report FY 2025-26 accessible via provided web-link and QR code.
• Emails sent to registered shareholders; non-registered recipients will access via link.
• Web-link for the Annual Report: https://www.rainbowhospitals.in/investors-relations/annual-reports.

Overview

• Consolidated Rainbow group runs 23 hospitals and 5 clinics across six Indian states.
• Main activity is health care services focusing on pediatric, perinatal, and women’s health.
• Reporting boundary is consolidated for FY2025-26 BRSR.
• Turnover is entirely from health care services.

Key ESG Risks & Opportunities

• Energy efficiency reduces emissions and costs; mitigated via audits, LED retrofits, and HVAC optimization.
• Water and waste management risk from biomedical waste and high water use; segregation and wastewater treatment.
• Occupational health and safety risk due to clinical exposure; mitigated by IPC, PPE, drills, and training.
• Privacy, cybersecurity risk from patient data; mitigated via encryption, access controls, backups, and audits.
• Service quality and patient safety present opportunities to strengthen brand and referrals.
• Digital transformation improves accessibility and efficiency; investment in secure platforms and analytics.
• Risk management and business continuity require enterprise risk registers and testing.
• Diversity, equity and inclusion improves collaboration and engagement.
• Employee learning, talent attraction and retention support service continuity.
• Medical ethics and regulatory compliance risk; emphasis on code of conduct and audits.
• Responsible procurement and supply chain resilience require due diligence and governance.

Governance & Policy Highlights

• CSR & ESG Committee provides board-level governance for sustainability matters.
• Anti-bribery and anti-corruption policy embedded in Code of Conduct; accessible on the website.
• Whistleblower, POSH, equal opportunity, and BRR policies translated into procedures.
• Independent assurance on BRSR Core Indicators performed by Adwin Advisory.
• Assurance covers nine core indicators under SEBI Master Circular; scope limited to core indicators.
• No penalties or fines reported; annual board review of NGRBC compliance.
• Policies translated to procedures and extend to value chain partners.
• Highest authority responsible for implementation not named; governance rests with board oversight.
• Board reviews NGRBC compliance annually.
• Policy web link for BR policies provided on company site.

Social Responsibility & Workforce

• Total workforce 6,397; permanent 4,724; female share 62%.
• Differently abled employees: 2, both female.
• Board female representation 14%; key management 33% female.
• Attrition FY2026: permanent male 34%, female 40%, total 37%.
• LTIFR for employees: 0; no fatalities recorded.
• Spending on employee well-being: 0.34% of total revenue.
• Parental leave: 100% return; female retention 59%, male 79%.
• Grievance channels include HRMS, whistleblower hotline, POSH helpline, BR policy.
• Training on human rights: 97% of employees; 99% permanent; 90% others.
• Remuneration: median BoD 30.75 L; KMP 1.87 Cr; employees 3.82 L.
• No standalone human rights due diligence; governance embeds human rights across policies.

Environmental Performance

• Total energy: 115,832 GJ; renewable share 31,523 GJ; non-renewable 84,310 GJ; intensity 6.80 GJ/INR Mn.
• Scope 1 emissions: 2,346 tCO2e; Scope 2 emissions: 12,702 tCO2e; intensity 0.88 tCO2e/Mn turnover.
• Water withdrawal 265,966 kL; consumption 150,887 kL; groundwater 136,195 kL; third-party 59,363 kL; municipal 70,408 kL.
• Waste generated 1,683.56 tonnes; BMW 365.68; e-waste 3.48; plastic 5.74; general waste 1,307.32.
• Solar rooftop at Rajahmundry; solar water heaters; estimated CO2 reductions ~204 t/year.
• Wastewater treated in-house via STP/ETP prior to discharge; NABH ISO 14001 certifications.
• PAT scheme: no designated consumption; compliance with environmental laws reported.
• Assurance by Adwin on GHG, water, energy and waste; 2025-26 scope covered.

Stakeholder Engagement & Complaints

• Stakeholders: investors, government, society, healthcare professionals, employees, suppliers, patients.
• Engagement channels include IR website, AGM, earnings calls, surveys, and meetings; frequency varies by group.
• Investors: quarterly/ongoing engagement; no material unresolved issues noted.
• Shareholders: 9 complaints filed in FY2026; 0 pending at year-end; 12 filed in FY2025.
• Customers: 30 complaints filed in FY2026; 3 pending; 27 resolved.
• Value chain partners and communities: complaints tracked; pathways via BR policies and contact channels.

Other Notable Metrics

• Inputs from MSMEs: 53% directly from MSMEs; 62% of inputs sourced from MSMEs in FY2025.
• Direct inputs from India: 100% of inputs sourced domestically.
• CSR turnover: 15,456.60 million; net worth: 16,890.57 million on a standalone basis.
• Training and awareness: 100% coverage for BoD, KMPs, and employees on BRR topics.
• Affiliations: 10 trade associations; NABH, NABH-linked healthcare bodies among members.
• Data privacy: no data breaches; privacy policy publicly available.
• Product safety: no recalls reported; consumer feedback channels actively solicited.
• Public policy: no explicit advocacy positions disclosed; policy links available on site.

Financial performance

• FY2026 revenue ₹17,030.8m, up 12.4%.
• EBITDA ₹5,441.7m, up 11.1%.
• PAT ₹2,815.4m, up 15.3%.
• EPS ₹27.41.
• Final dividend ₹3.50 per share; record date 22-Jul-2026; payout by 27-Aug-2026.

Acquisitions and expansion

• Acquired Prashanthi Medicare Private Limited; 76% equity + NCRPS.
• Acquired Pratiksha Women & Child Care Hospital Private Limited; 76% equity + NCRPS.

Capital structure and liquidity

• Consolidated net debt ₹8,570.9m; gearing 0.52x.
• Equity capital ₹1,015.59m; 101,379,156 shares outstanding.

Expansion strategy

• Hub-and-spoke model targets 5,000 beds in 5 years; capex ₹2,200 crore.